Beth Israel registers Phase II lifileucel TIL trial for kidney cancer with IovanceNov 9Trial updatealdesleukinIovance Biotherapeutics, Inc.
Pfizer raises 2026 guidance after Q3, reports pipeline progress and new CFONov 3Quarterly updateBioNTech SEC4 Therapeutics, Inc.
Merck registers new MK-8644 psoriasis trial; RA and HIV/HPV vaccine trials continueOct 30Weekly roundup, 11 itemscabazitaxeldexamethasoneUpdated
Iovance lifts 2026 revenue guidance to $410-420 millionSep 29FinancingaldesleukinIovance Biotherapeutics, Inc.
AstraZeneca posts Phase 3 LOGOS, KALOS asthma results; updates Soliris labelJul 2Weekly roundup, 5 itemsAstraZenecaAZD4045